Simmons D A, Winegrad A I
Cox Institute, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia.
Diabetologia. 1992 Aug;35(8):725-9. doi: 10.1007/BF00429091.
The (Na+,K+)-ATPase activity operative in rabbit aortic intima-media incubated with normal plasma levels of glucose and myo-inositol (70 mumol/l) is decreased when the glucose content of the medium is raised from 5 to 10 mmol/l or higher; this effect is prevented by aldose reductase inhibitors and by raising the myo-inositol content of the medium to 500 mumol/l. The decrease in (Na+,K+)-ATPase activity results from the loss of a component normally regulated (stimulated) by endogenously released adenosine through a receptor that stimulates phosphatidylinositol turnover in a discrete pool. The replenishment of this phosphatidylinositol pool selectively requires myo-inositol transport and is inhibited when increased polyol pathway activity impairs myo-inositol transport at a normal plasma level. Adenosine is a vasodilator, some endothelium-released vasodilators modulate the responses to vasoconstrictors by stimulating an increase in (Na+,K+)-ATPase activity in vascular smooth muscle. Whether adenosine mediates this effect in angiotensin II or norepinephrine-stimulated aorta was examined. Angiotensin II (100 nmol/l) and norepinephrine (1 mumol/l) evoked marked increases in (Na+,K+)-ATPase activity in aortic intima-media incubated with 5 mmol/l glucose and 70 mumol/l myo-inositol, which were inhibited when adenosine deaminase was added or the medium myo-inositol omitted to inhibit myo-inositol transport. Raising the medium glucose to 30 mmol/l inhibited the angiotensin II and norepinephrine-evoked increases in (Na+,K+)-ATPase activity, and this was prevented when tolrestat (10 mumol/l) was added or the myo-inositol content of the medium was raised from 70 to 500 mumol/l.(ABSTRACT TRUNCATED AT 250 WORDS)
在含有正常血浆水平葡萄糖和肌醇(70μmol/L)的条件下孵育的兔主动脉内膜 - 中膜中起作用的(Na +,K +)-ATP酶活性,当培养基中的葡萄糖含量从5mmol/L升高到10mmol/L或更高时会降低;醛糖还原酶抑制剂以及将培养基中的肌醇含量提高到500μmol/L可防止这种效应。(Na +,K +)-ATP酶活性的降低是由于内源性释放的腺苷通过刺激离散池中磷脂酰肌醇周转的受体正常调节(刺激)的一个成分的丧失。该磷脂酰肌醇池的补充选择性地需要肌醇转运,并且当增加的多元醇途径活性在正常血浆水平损害肌醇转运时受到抑制。腺苷是一种血管舒张剂,一些内皮释放的血管舒张剂通过刺激血管平滑肌中(Na +,K +)-ATP酶活性的增加来调节对血管收缩剂的反应。研究了腺苷是否在血管紧张素II或去甲肾上腺素刺激的主动脉中介导这种效应。血管紧张素II(100nmol/L)和去甲肾上腺素(1μmol/L)在含有5mmol/L葡萄糖和70μmol/L肌醇的主动脉内膜 - 中膜中引起(Na +,K +)-ATP酶活性显著增加,当加入腺苷脱氨酶或省略培养基中的肌醇以抑制肌醇转运时,这种增加受到抑制。将培养基中的葡萄糖提高到30mmol/L可抑制血管紧张素II和去甲肾上腺素引起的(Na +,K +)-ATP酶活性增加,当加入托瑞司他(10μmol/L)或培养基中的肌醇含量从70μmol/L提高到500μmol/L时,这种情况可被防止。(摘要截断于250字)